NCT07039136

Brief Summary

Mirror therapy has been shown to support motor recovery by stimulating neural mechanisms through visual feedback. Recent technological advancements, particularly in virtual reality (VR), have enabled the development of more immersive and interactive rehabilitation tools. This study focuses on evaluating the usability of a novel, Leap Motion-based Virtual Reality Mirror Therapy (VRMT) system designed to enhance upper limb rehabilitation in stroke patients by combining traditional mirror therapy principles with engaging, gamified digital environments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for not_applicable healthy

Timeline
7mo left

Started Jun 2025

Typical duration for not_applicable healthy

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Jun 2025Nov 2026

First Submitted

Initial submission to the registry

June 18, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 26, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

June 28, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

1.3 years

First QC Date

June 18, 2025

Last Update Submit

February 3, 2026

Conditions

Keywords

Virtual RealityMirror Therapy

Outcome Measures

Primary Outcomes (1)

  • Simulator Sickness Questionnaire

    "The SSQ evaluates 16 symptoms-including eye strain, nausea, sweating, and headache-using a four-point scale (none, mild, moderate, and severe). These symptoms are categorized into three overlapping subscales: nausea, oculomotor discomfort, and disorientation. Higher scores within each subscale reflect more intense experiences of simulator sickness. In military aviation contexts, a total SSQ score above 20 is typically interpreted as indicative of poor tolerance to simulation exposure. The total score generally ranges from 0 to 30, with higher scores indicating lower tolerance to simulated environments.

    One hour

Secondary Outcomes (4)

  • Presence Questionnaire

    One hour

  • Virtual Reality Sickness Questionnaire

    One hour

  • System Usability Scale

    One hour

  • Virtual Reality System Usability Questionnaire

    One hour

Study Arms (2)

Virtual Reality Mirror Therapy Group

EXPERIMENTAL

Participants will receive virtual reality mirror therapy using head-mounted devices.

Other: Virtual Reality Mirror Therapy

Sham Group

SHAM COMPARATOR

Participants will receive conventional mirror therapy with mirror box and then experience mirrored hand activities in virtual reality environment.

Other: Conventional Mirror TherapyOther: Sham Virtual Reality

Interventions

Participants will be seated on a chair with back support, their feet in contact with the ground, and both arms placed on a table. Activities to be practiced during the session will include wrist flexion and extension, forearm pronation and supination, finger flexion and extension, finger opposition movements, squeezing a cloth, grasping a round object, wiping a table, and object manipulation. The therapy program will follow a progression from simple to complex and functional movements throughout the session. Session will begin with basic exercises such as flexion and extension movements of the fingers, wrist, and elbow, with 10 repetitions for each movement.

Sham Group

Participants will experience virtual environments while seated and wearing a virtual reality headset, without interacting with the environment. The sham mirror therapy session will consist of two 15-minute segments with a 10-minute rest period in between.

Sham Group

Participants will be seated on a chair with back support, their feet in contact with the ground, and both arms placed on a table. Data from participants' right forearms will be collected using Leap Motion tracking. In the virtual reality environment, both the original and mirrored forearms will be displayed within the participants' field of view. The mirror therapy session will consist of two 15-minute segments with a 10-minute rest period in between. Activities to be practiced during the session will include wrist flexion and extension, forearm pronation and supination, finger flexion and extension, finger opposition movements, squeezing a cloth, grasping a round object, wiping a table, and object manipulation. The therapy program will follow a progression from simple to complex and functional movements throughout the session. Session will begin with basic exercises such as flexion and extension movements of the fingers, wrist, and elbow, with 10 repetitions for each movement.

Virtual Reality Mirror Therapy Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Stereo acuity score of 3552 arc/sec in the Titmus Fly Test
  • No prior virtual reality experience

You may not qualify if:

  • Severe sensory impairments (vision or hearing)
  • Being diagnosed with neurological disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Health Sciences Bolu Abant Izzet Baysal University

Bolu, Merkez, 14100, Turkey (Türkiye)

RECRUITING

Bolu Abant Izzet Baysal University Department of Physiotherapy and Rehabilitation

Bolu, 14300, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • ramazan kurul, Ph.D

    Abant Izzet Baysal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective parallel group with single-blinded design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof

Study Record Dates

First Submitted

June 18, 2025

First Posted

June 26, 2025

Study Start

June 28, 2025

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) related to primary and secondary outcomes will be shared.IPD will be available 6 months after publication of the main study results. Data will be shared with qualified researchers affiliated with academic or medical institutions, upon request and subject to ethical approval or data use agreements if applicable.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After publication, the study will be available indefinitely.
Access Criteria
Researchers may submit a data request by contacting the corresponding author via email. Approved users will receive access through a secure, password-protected institutional data-sharing platform or encrypted file transfer.

Locations